13.75 USD
▲-0.13+2.84%
盘后 13.60 +1.72%
2026-08-03
市值
$2.07B
市盈率
—
EPS
-5.44
股息率
—
52 周区间
7.48 – 18.57
成交量
2.41M
Beta
3.16
目标价
22.93
52W 低 7.4852W 高 18.57
价格走势
公司简介
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim...